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Effects of inhibition of prostaglandin synthesis
on fetal renal function
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Effects of inhibition of prostaglandin synthesis on the fetal renal
function. The role of renal prostaglandin production on the control of
renal blood flow (RBF) and renal function was studied in eight
chronically catheterized fetal lambs during the last trimester of gesta-
tion by using indomethacin as an inhibitor of prostaglandin synthesis.
Following administration of indoniethacin. RBF decreased significantly
(—7.44 2.04 mI/mm) whereas significant increases in filtration fraction
(*3.92 0.85%) and renal vascular resistance (+0.41 0.13 mm Hg
ml' ' mm 1) were observed. Significant changes in glomerular perfu-
sion rate were observed only in the inner portion of the cortex. No
changes in GFR were demonstrated. Following administration of indo-
methacin, significant increases in fetal urinary sodium (+22,2 7.03
Eq/min) and chloride excretion (+ 18.2 6.26 rEq/mm) were found
despite a decrease in RBF. No changes in potassium excretion were
seen. A significant increase in tJ0 ( + 100 25.9 niOsni/kg l'tO) not
associated with significant changes in urinary flow rate was also
demonstrated following indomethacin. Finally, fetal administration of
indomethacin produced a significant decrease in plasma renin activity
(—2.70 0.65 ng/ml/hr) not associated with changes in plasma aldoster-
one concentration. The present data are consistent with the idea that
prostaglandins are important modulators of RBF and renin secretion
during fetal life. The inability of indomethacin to render the urine
hypertonic indicates that the inability of the fetal kidney to concentrate
is probably not due to endogenous activity of the renal prostaglandin
system. The increase in sodium chloride excretion with a concomitant
reduction of RBF is a pattern not previously reported following
inhibition of prostaglandin production. In addition to their effects on
RBF and renin release, renal prostaglandins in the fetal kidney may
have tubular effects on sodium and chloride absorption that are
opposite to those generally ascribed to adult kidneys.
Effets de l'inhihition de Ia synthèse de prostaglandine sur Ia fonction
rénale du foetus. L,e rOle de Ia production rénale de prostaglandine stir Ic
contrOle du debit sanguin renal et de Ia fonction rCnale a etC CtudiC chez
8 agneaux cathétCrisCs de facon chi'onique pendant Ic dernier trimestre
de Ia gestation en utilisant l'indomCthacine comme inhihiteor de Ia
synthèse de prostaglandine. Après l'administration d'indomCthacine. Ic
debit sanguin renal diminue significativement (—7.44 2.04 mI/mint en
même temps que des augmentations significatives de Ia fraction filtrCe
(+3,92 0,85%) et de Ia résistance vasculaire rCnale sont ohservées
(0.41 0,13 mm Hg' ml ' mm ). Des modifications significatives du
debit de perfusion glomerulaire n'ont été ohservCes que dans Ia partie
profonde do cortex. II na pas été mis en evidence de diminution du
debit de filtration glomerulaire. AprCs administration d'indométha-
cine, one augmentation significative de l'excrétion orinaire dc sodium
(+22,2 7,03 iEq/niin) et de chlore (+ 18.2 6.26 iEq/min) a etC
ohservée malgré Ia diminution do debit sanguin renal. II na pas Cté
constaté d'augmentation de l'excrCtion do potassium. Une augmenta-
tion significative cle U,,, (+ 100 25,9 mOsm/kg HO) non associCe a
des modifications significatives du debit urinaire a aussi etC misc en
evidence apres l'administration d'indométhacine. Enfin, ladministra-
tion d'indomCthacine au foetus a produit one diminution significative de
l'activité rénine plasmatique (—2.70 0,65 ng/ml/hrt non associée a one
modification de Ia concentration plasmatique d'aldostCrone. l,es rCsul-
tats sont en accord avec l'idCe scIon laquelle les prostaglandines
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seraient des modulateurs importants do debit sanguin renal et de Ia
sCcrCtion de rCnine au coors de Ia vie foetale, L,'incapacité de l'indo-
méthacine a rendre l'urine hypertonique indique que l'incapacite a
concentrer du rein foetal n'est prohablement pas liée a lactivité
endogCne do système de prostaglandine renal. Laugmentation de
l'excrCtion renale de chlorure de sodium en mCme temps qoe Ic debit
sangoin renal diminoe est one niodalitC qui n'a pas etC rapportCe
jusqu'ici a Ia suite de l'inhihition de Ia production de prostaglandine. En
plus de leurs effets sur Ic debit sanguin renal et Ia liberation de rénine,
les prostaglandines rénales do rein foetal peovent avoir des effets
tubulaires sur l'ahsorption de sodium et de chlorure a 'oppose de ceux
gCneralement dCcrits pour le rein adulte.
Factors controlling renal hemodynamics and renal function.
as well as factors modulating renin secretion during fetal life.
are not well understood. Terragno. McGiff, and Terragno [I]
suggested that prostaglandins produced by the fetal kidney may
he involved in the regulation of renal blood flow (RBF) and
renal function. More recently Millard, Baig. and Vatner [21
demonstrated a transient decrease in fetal RBF following inhibi-
tion of prostaglandin synthesis in chronically catheterized fetus-
es. But neither of these previous studies [I. 2] investigated the
role of renal prostaglandin production on the excretory func-
tions of the fetal kidney.
Previously reported experiments from this laboratory have
demonstrated that the fractional excretion of sodium and chlo-
ride is elevated during fetal life [3]. We have also demonstrated
a relative inability of the fetal kidney to produce a concentrated
urine [4]. Whether endogenous prostaglandins contribute to this
saliuresis and concentrating defect in the fetal kidney is in-
known. In adult animals. prostaglandins have been shown to
enhance renal sodium and water excretion [5].
'l'he role of prostaglandins as a possible modulator of renin
secretion has been previously suggested in adult animals [5].
But such a role has not been demonstrated during fetal life. A
recent study by Moutquin and Liggins [61 suggests that there is
no relationship between renal production of prostaglandins and
plasma renin activity (PRA) in the fetal lamb.
The present protocol was therefore designed to determine the
influence of endogenous renal prostaglandins on the control of
Received for publication January 19, 1981
and in revised form March 17, 1981
0085-2538/8l/0020-0621 $01.40
© 1981 by the International Society of Nephrology
622 Matson et at
RBF and renal function in chronically catheterized fetal lambs,
With indomethacin as an inhibitor of prostaglandin synthesis,
these studies also evaluated the possible interrelationship be-
tween the renin-angiotensin system and renal prostaglandin
synthesis during fetal life.
The results indicate that inhibition of prostaglandin synthesis
by indomethacin reduces glomerular perfusion predominantly
in the juxtamedullary nephrons, increases sodium chloride
excretion, reduces PRA, and does not improve the concentrat-
ing ability of the fetal kidney.
Methods
An/ma/preparation and surgical procedures. Eight pregnant
mixed-breed Dorset Suffolk ewes, between 117 and 137 days'
gestation (term, 145 days), were obtained from a local source,
Gestational ages were estimated according to the induced
ovulation technique [7], which consists of synchronizing estrus
with the use of vaginal sponges impregnated with 40 mg of
flurogestone actetate (Synchro-mate, Searle) followed 12 days
later with 500 IU of pregnant mare serum gonadotropin
(Equinex, Ayerst Co.) administered i.m. to the ewe to induce
ovulation. Forty-eight hours later, a ram is introduced to mate
for a period of 24 hours. The fetal heart is monitored 60 days
later to confirm pregnancy. Using such a technique, we were
able to determine that fetal body wt (kg) = [0.096 x gestational
age (days)] — 9.2228 (r 0.85, P < 0.001) [31.
Prior to surgery, the animals were fasted for 48 hours.
Anesthesia of the ewe and surgery of the fetus were performed
as described previously [41. The pregnant ewe was anesthetized
by a mixture of 1.0 to 1.5% halothane, 33% oxygen, and 66%
nitrous oxide given by endotracheal tube. Thereafter, the
uterine horn was exposed, and through a small uterine incision,
polyethylene catheters (1.D., 0.86 mm; O.D., 1.27 mm) were
inserted into the fetal femoral vein and in both femoral arteries
for a distance of approximately 5 cm and secured with silk
ligatures. Through the same incision, the umbilical cord was
located, the urachus identified and ligated distally, and a French
3/2 feeding tube inserted and advanced approximately 4 to 6cm
into the fetal bladder, The presence of urine flowing in the
catheter indicated good positioning of the urachal catheter. The
catheter was then closed with a sterile three-way stopcock. All
catheters were secured with silk ligatures, and a drop of methyl-
2-cyanoacraylate (Eastman 910 adhesive, Eastman Chemical
Products, Inc.) was applied for tissue adhesion. An additional
catheter was also secured in the amniotic cavity for intrauterine
pressure recording. Thereafter, the hind limbs were replaced,
and the fetal membranes, uterine cavity, and abdominal wall
were closed in separate layers with 1-0 catgut sutures. All
catheters were exteriorized through a s.c. tunnel and placed in a
cloth pouch on the ewe's flank, after which the abdominal skin
was closed,
Following surgery, the ewes were kept in a restricted area
and fed a standard diet. One gram of ampicillin was given i.m.
to the ewe and infused in the amniotic cavity through the
amniotic catheter for the first 3 days following surgery and
every time thereafter that the catheters were flushed. A recov-
ery period of at least 5 days was allowed before any experiment
was carried out. It has previously been shown that recovery of
fetal renal function from surgical stress occurs in 3 to 6 days [8].
Physiologic studies. During physiologic studies, the ewe was
transferred into a small cart permitting it to stand only. The
GFR in the fetus was determined by a constant infusion of 1251
sodium iothalamate (Glofil, Abbott Laboratories). A priming
dose of iothalamate (0.45 p.Ci/kg) was administered followed by
a constant infusion of 0.1 Ci/kg/min in 5% dextrose solution at
a rate of 0.09 mI/mm. An equilibration period of 1 hour was then
allowed before the start of the first renal clearance period.
After the equilibration period, three 20-mm control urine
collection periods were performed. Following the control urine
collection periods, the fetus was given an i.v. bolus of 2 mI/kg of
0.1 M neutral phosphate buffer (pH, 7.4), used as vehicle for
administration of indomethacin. A 20-mm stabilization period
was allowed, and then three more urine collection periods were
made. Finally, indomethacin (5 mg/kg) dissolved in neutral
phosphate buffer (2 mI/kg) was given as an i.v. bolus to the
fetus: the actual dose of indomethacin given after determination
of fetal weight at the end of the experiment was 5.02 0.29 mg/
kg. Following indomethacin administration, a 20-mm stabiliza-
tion period was allowed, and four additional urine collection
periods were made. All urine collection periods were 20 mm
each.
At the midpoint of each urine collection period, arterial blood
was obtained for determination of plasma electrolyte concentra-
tion (sodium, potassium, and chloride), plasma osmolality,
hematocrit, total plasma protein concentration, arterial blood
gases (Po2 and Pco2), arterial pH, and plasma concentration of
'251-sodium iothalamate. Fetal PRA and plasma aldosterone
concentration were determined at the beginning and at the end
of both control urine collection periods, and during the first,
second and fourth clearance periods following indomethacin
administration, Fetal blood samples were replaced with an
equal amount of maternal blood to avoid any hemodynamic
effect of sampling. At the end of each clearance period, the
amount of urine collected was measured and analyzed to
determine the osmolality and concentrations of electrolytes
'251-sodium iothalamate, and prostaglandins (POE and PGF2).
In every fetus studied, RBF was measured as previously
described [4, 9] using radioactive microspheres 15 3 i in
diameter (3M Co., St. Paul, Minnesota). Spheres were provided
with either 85Sr, 465c, or 41Ce incorporated into their structure
and were suspended in 10% dextran to which a trace of
dispersing agent, Tween 80, had been added. Prior to injection,
microspheres were thoroughly mixed and placed in an ultrason-
ic bath 3 to 5 mm to disperse aggregates. Immediately following
the three "control" urine collection periods, approximately 4.0
x l0 microspheres were suspended in 3 ml of 0.9% saline
solution in a 6-mi plastic syringe and were injected throughout a
30-sec period into the fetal inferior vena cava and then immedi-
ately flushed with 3 ml of 0.9% saline.
To obtain a lower body independent reference sample, we
collected femoral arterial blood during a period of 3 mm
beginning 20 sec before the microsphere injection and at a
withdrawal rate of 1.1 mI/mm using an infusion-withdrawal
Harvard pump. A second bolus of radioactive microspheres,
labeled differently than the first bolus, was injected after the last
urine collection period following the administration of the
neutral phosphate buffer vehicle for indomethacin. The final
bolus of radioactive microspheres, labeled differently than the
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first two, was administered at the end of the fourth urine
collection period following indoniethacin infusion. Previous
experiments in our laboratory [4, 9] have demonstrated that
sequential infusion of microspheres into the fetal circulation
does not modify the fetal renal function and that spheres 15 p. in
diameter are most suitable to study blood flow distribution in
fetal lambs because spheres of smaller diameter (9 p.) recircu-
late.
In every experiment, fetal arterial, venous, and amniotic
pressures were recorded continuously using Statham P23Db
pressure transducers (Statham Instruments Division, Gould,
Inc.) and a Beckman R61 I recorder. Fetal mean arterial blood
pressure (MABP) and venous pressures were corrected for
amniotic pressure. Fetal heart rate was monitored with a
cardiotachometer triggered from the fetal arterial pressure
pulse.
Within 1 hour following the completion of the experiment, the
fetus was killed by a bolus of supersaturated potassium chloride
solution and the ewe by a bolus of pentobarbital. Catheter
positions were confirmed, and the kidneys were harvested from
the fetus.
Analytical methods. Blood for pH, Pco2, and Po2 was
collected anaerobically in heparinized glass syringes and mea-
surement immediately determined with the appropriate pH,
Pco2, and Po2 electrodes at 39° C using an acid-base analyzer
(PHM72MK2 Model Radiometer Co., Denmark). Plasma and
urine concentrations of sodium and potassium were determined
by flame photometry using lithium as an internal standard (IL
443 Flame photometer) and chloride by potentiometric titration
(Radiometer CMT 10 chloride titrator). Osmolality in plasma
was measured by freezing-point depression using an Advanced
osmometer (Advanced Instruments, Massachusetts). The con-
centration of '251-sodium iothalamate in plasma and urine was
determined by gamma emission of 1251 using a gamma spec-
trometer (Beckman 300, Beckman Instruments, Inc., Missouri
63141). Plasma protein content of fetal blood was determined
using a refractometer (National Instrument Co., Baltimore,
Maryland).
Gamma emission generated from the microspheres was mea-
sured from both fetal kidneys and reference femoral arterial
blood samples. Immediately after removing the kidneys from
the animal they were placed in formalin 10%, then weighed and
cut into two equal halves along the longitudinal axis of the
kidney as described previously [101. One half was then cut in
midlongitudinal sections of less than 1 g and placed in counting
vials containing a predetermined amount of 10% formalin in
such a way as to prevent air tissue interfaces that could alter the
counts. From the second half, one or two midlongitudinal
sections of approximately 1.5-mm thick were cut. From these
sections, five blocks, approximately 3- to 4-mm broad with the
corticomedullary junction parallel to the surface, were selected.
The cortex was separated from the medulla just below the
arcuate vessels and divided into four equally thick slices by cuts
paralleling the outer surface and the corticomedullary junction
as previously described by Olbing et al [10]. Each slide,
designated zone I to zone IV from the subcapsular area to the
juxtamedullary cortex, was weighed in preweighed counting
tubes containing 1 ml of 10% formalin and then radioactivity
determined. The energy window ranges were set between 237
and 293 KeV for 85Sr, 367 and 578 KeV for 46Sc, and 74 and 102
KeV for '41Ce. Isotope separation was performed using stan-
dard calculation [4].
After the determination of radioactive counts in every zone
was made, all slices of kidney from the same zone were pooled
and digested together in 50 ml of 12% hydrochloric acid at 37° C
for 18 hours. After digestion, the kidney tissues were washed
with water, and brought to a final volume of 10 ml. Thereafter,
0.4 ml of this dilution was placed in a counting chamber and the
number of glomeruli determined under microscope. For each
zone, ten determinations were done. To be sure that only
perfused glomeruli were counted, we infused 100 ml of India ink
into the animal just before sacrificing it with a lethal dose of
potassium chloride.
All blood samples for PRA measurements were collected in
chilled tubes containing potassium EDTA, kept on ice, and
centrifuged at 4° C. PRA was determined by radioimmunoassay
of generated angiotensin I as previously described [3, 11].
Plasma aldosterone was determined by radioimmunoassay as
previously described [3].
Urine samples for prostaglandins determination were collect-
ed under ice, then immediately frozen at —70° C. Urine samples
were extracted with ethylacetate and separated into classes by
silicic acid chromatography, The urinary PGE and PGF2 levels
were determined by radioimmunoassay using specific anti-
serums. The technique, reliability, and full characterization of
each assay have been reported previously [12, 13].
Computations and data analysis. RBF was determined ac-
cording to the following formula: RBF (mI/mm) = total kidney
counts x reference flow (RF) from the femoral artery (mI/mm)
per total femoral blood counts (QF). Renal vascular resistance
(RVR) was determined according to the following formula:
RVR (mm Hg ml min) = RPP/RBF, where RPP is the
renal perfusion pressure estimated to be equal to the aortic
pressure minus the inferior vena cava pressure and RBF is the
renal blood flow expressed in mI/mm. The filtration fraction
(FF) was determined according to the following formula: FF
(%) = GFRIRPF, where GFR is the glomerular filtration i-ate
(mI/mm) and RPF is the renal plasma flow (mI/mm). RPF was
determined according to the following formula: RPF = RBF x
(1 —hematocrit). Glomerular perfusion rate (GPR) was deter-
mined according to the following formula: GPR (ni/mm) = [c1K
RF] [QF . G], where qK corresponds to the radioactivity counts
in a particular zone of the cortex, and G to the absolute number
of perfused glomeruli in that particular zone of the cortex.
Osmolar clearance was determined as follows: Csm (mi/mm)
(Uosm V)IPosm, in which UOsm and POsm represent urine and
plasma osmolality in mOsm/kg H20 and V the urinary flow rate
in mi/mm. The solute free water clearance (C,o) was calculat-
ed as the difference between the urine flow (V) and the osmolar
clearance (Cosm): CHO = V—Cosm. TCH2O represents negative
free water clearance or free water reabsorption.
Student's paired t test and analysis of variance were used to
test for differences among means of two or more populations.
To determine the effect of time on the changes seen following
indomethacin, we performed a two-way analysis of variance.
Unless otherwise noted, changes are significant with a P
value of less than 0.05 in a two-sided significance limit. Results
are presented as mean values for control periods and indometh-
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(N = 8)a
Control Indomethacin Changeb
pH 7.38 0.01 7.35 0.02 —0.03 0.01
Pco2, mm Hg 41.0 1.90 42.3 1.93 1.33 1.41
P02, mm Hg 22.2 2.03 23.8 1.66 1.64 0.83
Na, mEqiliter 149.7 1,29 150.9 1.67 1.18 0.91
K, mEqlliter 4.2 0.24 4.2 0.26 0.04 0.08
C1, mEqiliter 106.3 2.83 l06.2 2.16 —0.13 0.58
Osmolality,
mOsmlkg 1120 293 1.38 293 2.15 0.38 2.50
Hematocrit, % 32.9 1.65 34.1 1.72 1.04 0.80
Total protein, g/dl 3.4 0.13 3.8 0.11 0.46 0.08






mmHg'mi min 0.88 0.06 1.29 0.16 0.41 0.13r
MABP, mm Hg 39.6 1.05 45.8 2.28 6.3 l.43c
Heart rate, beats/mm 183 5.33 195 7.52 11.5 6.49
N is the number of animals studied; TRBF, total renal blood flow;
FF, filtration fraction; RVR, renal vascular resistance; MABP, mean
arterial blood pressure.




Zone 1 72.4 23.4 62.1 23.0
-
—10.3 5.60
Zone II 60.0 11.8 47.4 7.5 —12.6 7.10
Zone 111 61.3 11.0 48.0 9.4 —13.4 4.90c
Zone IV 72.2 13.2 48.5 13.0 —23,7 5.00w
acm periods as well as the mean difference (A) between the
periods plus or minus the SEM.
Results
Because no differences were found between the three control
urine collection periods and the three periods following the
administration of the neutral phosphate buffer used as vehicle
for indomethacin, those six periods were pooled and are
referred to as control in the text.
The fetal arterial blood values are summarized in Table 1.
After indomethacin was administered, there was a modest but
significant increase in total protein concentration.
The effects of indomethacin on fetal renal hemodynamics are
presented in Table 2. Following the administration of indometh-
acm, total renal blood flow decreased whereas filtration fraction
and renal vascular resistance increased, Arterial blood pressure
increased from 39.6 1.05 to 45.8 2.28 mm Hg but there were
no changes in heart rate. Venous pressure was unchanged.
Changes in glomerular perfusion rate (GPR) following indo-
methacin were determined in 6 fetuses and the results are
presented in Table 3. Although GPR tended to decrease in each
cortical zone examined, significant changes were found only in
the inner cortex (zones III and IV). No significant redistribution
of GPR between cortical zones was found following indometh-
acm administration.
The effects of indomethacin on GFR, electrolyte excretion
and renal concentrating ability are shown in Table 4. Following
the administration of indomethacin, the fractional excretion of
sodium and chloride increased from 7.27 1.38 to 12.4 2.89%
and 5.76 1.04 to 12.04 2.49%, respectively. Potassium
excretion was unchanged. An increase in urine osmolality
(Uosm) of 100.9 mOsm/kg H20 not associated with changes in
urinary flow rate (V) was also demonstrated following indo-
methacin. In 6 out of 8 fetuses, CH2O decreased following
indomethacin administration. But, in only one fetus was nega-
tive free water clearance (—0.09 mI/mm) and hypertonic urine
(Uosm = 448 mOsm/kg H20) observed following indomethacin.
This fetus was the oldest of the 8 examined and was near term
(137 days; term being 145 days).
The adequacy of renal prostaglandin synthesis inhibition by
indomethacin was assessed by determination of urinary excre-
tion of PGE and PGF2. The excretion rate of both PGE and
PGF2 was significantly reduced by indomethacin. PGE excre-
tion decreased by 60.1 5.9% (from 0.70 0.12 to 0.27 0.04
ng/min, P < 0.01) and PGF2 excretion by 58.8 7.1% (from
0.92 0.15 to 0.27 0.05 ng/min, P < 0.01). The reduced
excretion occurred 20 mm following indomethacin administra-
tion and was stable throughout the period of observation,
Administration of indomethacin to the fetus produced de-
creases in plasma renin activity (PRA) in each of the 8 fetuses
studied (Table 5). The mean reduction was 46.1%. No changes
in fetal plasma aldosterone concentration were demonstrated.
Discussion
The results of the present study demonstrate that systemic
administration of the cyclooxygenase inhibitor indomethacin to
the resting fetal lamb (1) produced a decrease in renal blood
flow together with an increase in renal vascular resistance, (2)
increased sodium chloride excretion and urine osmolality with-
out changing urine flow rate, and (3) decreased plasma renin
activity without affecting plasma aldosterone concentration.
Taken together, these results suggest that endogenous renal
prostaglandins modulate renal function in the fetus. The nature
of the modulation of these parameters of renal function share
some similarities with the adult kidney. But the complete
pattern of functional alteration is different than that observed in
most adult mammals. The results support the notions that
endogenous prostaglandins increase renal blood flow and renin
release but have complex actions in the regulation of sodium
chloride excretion.
The fall in fetal renal blood flow in unstressed fetal lambs
(Tables 2 and 3) contrasts with results generally obtained in
conscious adult animals [14—16] and man [171 where indometh-
Table 1. Changes in fetal blood values following indomethacin
N is number of animals studied.
Mean difference between control and indomethacin periods.
P < 0.05.
41.8 1.75 34.3 2.02 —7.44 2.04c
9.33 0.71 13.25 l.5l 3.92 0.85
Table 3. Changes in fetal glomerular perfusion rate following
indomethacin (N = 6)
N is the number of animals studied.
b Mean difference between control and indomethacin periods.
P < 0.05.
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Table 4. Changes in renal function following indomethacin (N = 8)a
Control Indomethacin Chang&'
V, mI/mm 0.72 0.09 0.64 0.12 —0.08 0.15
GFR, ml/min 2.66 0.21 2.69 0.30 0.04 0.27
FENa, % 7.27 1.38 12.40 2.89 5.25 l.76c
UNV, p.Eq/min 27.59 9.75 49.79 10.36 22.20 7.03c
FE1, % 5.76 1.04 12.04 2.49 6.27 2.39c
U1V, .EqImmn 15.86 3.02 34.07 6.65 18.21 6.26c
FEK, % 59.81 24.48 49.66 20.20 —10.03 8.77
UKV, p.Eq/min 7.39 3.52 6.76 2.75 —0.62 1.73
Com, mI/mm 0.29 0.04 0.45 0.06 0.15 0.05c
CH,O, mI/mm 0.42 0.06 0.2! 0.09 —0.21 0.11
Um, mOsm/kg JfO 123 7.61
-
224 25.41 100.9 25.97c
a N is the number of animals studied; V, urine flow; GFR, glomerular filtration rate; FE, fractional excretion; UV, excretion rate; Cosm, osmolar
clearance; CH2O, free water clearance.
b Mean difference between control and indomethacin periods.
P < 0.05.
Table 5. Changes in fetal plasma renin activity (PRA) and plasma
aldosterone following indomethacin (N = 8)'
Control Indomethacin
Changeb_—
PRA, ng/ml/hr 5.86 1.05 3.15 0.72 —2.70 0.65a
Aldosterone,pg/m/ 36.5 9.17 39.9 8.271 3.5 5.34
a N is the number of animals studied.
b Mean difference between control and indomethacin periods.
a P < 0.05.
acm does not modify renal hemodynamics. Although we cannot
exclude differences due to species, the available evidence
suggests that the hemodynamic changes may be relatively
specific for the fetus. Osborn, Hook, and Bailie [18] has shown
in unanesthetized newborn piglets that, like the adult, mdc-
methacin does not affect renal hemodynamics. In favor of the
idea that this effect is accentuated in the fetus, Terragno et al [1]
demonstrated that blood vessels dissected from fetal pig kid-
neys had a higher capacity to produce and release PGE2 and
PGI2 when compared with adults. In a recent study, Millard,
Baig, and Vatner [2] demonstrated a transient reduction in fetal
renal blood flow following administration of either meclofena-
mate or indomethacin to chronically catheterized fetal lambs. In
contrast to the present study, they found only a transient (30-
mm) decline in fetal blood flow following inhibition of prosta-
glandin synthesis rather than a persistent reduction (>100 mm).
Differences in dose of indomethacin cannot explain the differ-
ence. Nevertheless, because total fetal cardiac output is un-
changed during prostaglandin inhibition [19], the present study
and the study by Millard et al [2] suggest that prostaglandins
produced by the fetal kidney are important modulators of renal
vascular tone during fetal life. Because the reduction in RBF is
associated with a significant increase in filtration fraction
without appreciable changes in GFR, one might speculate that
prostaglandins produced by the fetal kidney control more
specifically the efferent arteriolar tone.
The present study also demonstrated a reduction in blood
flow to the inner portion of the fetal cortex following indometh
acm administration; glomerular perfusion rate (GPR) decreased
significantly in both zones Ill and IV whereas no significant
changes were observed in zones I or II (Table 3). In anesthe
tized adult dogs, Kirschenbaum et al [20] also observed a
decrease in intrarenal blood flow to the inner portion cf the
cortex following indomethacin or meclofenamate. But, in con-
trast to the results in adult animals where this effect is observed
only in anesthetized or stressed animals [20] but not in con-
scious animals [16], in the present study inhibition of prosta-
glandin synthesis produced changes in GPR in unanesthesized
and unstressed fetuses.
The results regarding the effects on fetal renal tubular func-
tion demonstrated that inhibition of prostaglandin synthesis
increased urine osmolality by increasing sodium chloride excre-
tion without significant changes in urinary flow rate (Table 4).
In only one fetus (which was near-term) was hypertonic urine
(Uosm = 448 mOsm/kg H20) excreted. Thus, it appears that the
inability to excrete a concentrated urine by the (immature) fetus
is not due to a relative overproduction of renal prostaglandins
as previously suggested [21].
The increases in fetal urinary sodium and chloride excretion
occurred despite a decrease in fetal renal blood flow. The
mechanisms regarding the regulation of sodium chloride ecre-
tion following systemic administration of cyclooxygenase inhib-
itors are not well understood. There is evidence for an increase
[22], a decrease [23], and no change [24] in sodium chloride
excretion after PG inhibition in several adult animal models.
But, under conditions of anesthesia or sodium chloride deple-
tion, PG inhibition generally causes sodium chloride retention
[25, 26]. Such an effect is almost always observed when there is
a concomitant fall in renal blood flow. Thus, the present
combination of findings are at variance with those observed in
adults of other species.
There are three reasonable possibilities that could explain the
saliuresis in the present setting. (I) The increase in arterial
pressure following indomethacin administration (Table 2) might
have caused a "pressure natriuresis" although the magnitude of
the pressure elevation is less than is needed to produce natriure-
sis in adult animals [27, 28] and "pressure natriuresis" is
accompanied by kaliuresis [29]. (2) Endogenous prostaglandins
may have an opposite effect on fetal tubular sodium chloride
transport than they have in most adult animals. The presently
available information indicates that prostaglandins inhibit sodi-
um and chloride absorption in the medullary thick ascending
limb of Henle's loop [30] as well as sodium absorption and
potassium secretion in the cortical collecting tubule [31, 321.
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But PGE1 stimulates sodium absorption in the toad bladder [331
and if such an effect were operative in the fetal kidney,
indomethacin administration would produce a natriuresis. (3)
Finally, indomethacin administration might produce the saliure-
sis by producing an increase in the 'backleak" of sodium
chloride into the tubular fluid. For example, if indomethacin
administration resulted in an accumulation of sodium chloride
in the renal medulla as it does in adult rats [34], sodium chloride
might "leak" back into the tubular lumen (perhaps across the
terminal collecting tubule) and in this way produce the observed
saliuresis.
Whatever the mechanism of the saliuresis, there is clear
evidence that inhibition of endogenous prostaglandin produc-
tion can produce oppositely directed effects on sodium chloride
excretion. Such effects appear to be separable from changes in
hemodynamics. Although the mechanism of the indomethacin-
induced saliuresis might be unique to the fetus, two other
reports have also documented saliuresis without kaliuresis in
adult animals [22, 35]. Endogenous renal prostaglandins thus
may have tubular effects of sodium chloride transport that vary
according to the experimental setting. Further experimentation
will be required to identify the site and mechanism of the
saliuretic effect of prostaglandin inhibition.
Plasma renin activity was reduced but plasma aldosterone
concentration was unaffected following indomethacin adminis-
tration. This decrease in PRA was evident despite a reduction in
fetal renal blood flow and an increase in renal vascular resist-
ance. In a recent study in chronically catheterized fetuses,
Moutquin and Liggins [6] found no increase in plasma prosta-
glandin E following stimulation of fetal PRA by furosemide and
concluded that there is no relationship between renin release
and renal prostaglandin production in the fetal lamb. But
because determination of plasma prostaglandins does not re-
flect renal production and because urinary PGE excretion was
not determined [61, one cannot conclude that renal prostaglan-
din production does not modulate renin secretion during fetal
life. On the contrary, the present results suggest that prosta-
glandin synthesis by the fetal kidney, as in adults [36, 37], may
be an important modulator of renin secretion during fetal life.
The absence of changes in fetal plasma aldosterone concen-
tration despite the decrease in fetal PRA following indometh-
acm is in apparent contrast to recent results found in adult
animals [38, 39]. It has been previously observed that PGE
stimulates the release of aldosterone from adult adrenal gland
[39]. More recently, Campbell et a! [38] demonstrated in adult
rats that indomethacin reduced the angiotensin-induced aldos-
terone release as well as the basal aldosterone level. Therefore,
the absence of changes in fetal plasma aldosterone concentra-
tion during prostaglandin synthesis inhibition suggests that
prostaglandins do not modulate the basal level of plasma
aldosterone concentration during fetal life as in adults. These
results might also reflect a prolonged half-life of aldosterone in
the fetus; the present protocol was not designed to study this
aspect, however.
In summary, the present data support the idea that prosta-
glandins produced by the fetal kidney are important in modulat-
ing renal blood flow in unstressed fetuses. The data are also
compatible with a role for endogenous prostaglandins in the
regulation of renin release during fetal life. The present study
demonstrates that inhibition of prostaglandin synthesis during
fetal life is associated with a natriuresis and choliuresis without
change in potassium excretion. Finally, the present results
suggest that the inability of the fetal kidney to concentrate is not
due to the endogenous activity of fetal renal prostaglandin
synthesis.
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